A Q fever cluster among workers at an Abattoir in South Western Sydney

Slides:



Advertisements
Similar presentations
Milk Mayhem The following slides represent a realistic public health crisis event and you are charged with developing first messages for the public.
Advertisements

Ebola Facts October 28, /28/14 Identify, Isolate, Inform: ED Evaluation and Management The following diagram provides guidance on evaluation and.
Any of the following risk factors within 3 weeks (21 days) before onset of symptoms 1,2 : Contact with blood or other body fluids of a patient known to.
Bioterrorist Agents: Tularemia
What is Ebola? Ebola is a rare and deadly disease caused by infection with the Ebola virus. It is only spread by direct contact with an infected person's.
Ebola Virus Disease. EVD Description Hemorrhagic fever with case fatality rate up to 90% Endemic areas: Central and West Africa Wildlife reservoir: bats.
EBOLA OUTBREAK 2014 There has never been an outbreak this size and severity.
Q Fever By: Mandana Ershadi-Hurt. Q fever is a zoonotic disease caused by Coxiella burnetii, a species of bacteria that is distributed globally. Q fever.
INTEGRIS Preparedness Plan: Ebola Virus Disease (EVD) With the spread of Ebola to the U.S., ensuring our employees and communities are safe is the utmost.
CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION Epidemiology Investigation for Ebola Virus Disease Lei Zhou, MD, Epidemiologist Public Health Emergency.
EBOLA Virus Disease August 22, What is Ebola Virus Disease (EVD)? Ebola virus disease (also known as Ebola hemorrhagic fever) is a severe, often-fatal.
Brucellosis By: Leah Kasheta.
Swine Flu update Jacob Kool Communicable Disease Surveillance and Response WHO South Pacific 29 April 2009 WHO/WPRO.
Health Surveillance What you need to know. Health Surveillance The University has a Health Surveillance policy.
Hepatitis A, B, C Direct Inoculation
Infectious Disease Surveillance Section
WHO guidelines for investigation and control of Foodborne Diseases outbreak Dr. Christina Rundi Ministry of Health, Malaysia.
Copyright Medical Group Management Association. All rights reserved. Name, credentials Organization Date Preparing Your Office Practice for Disaster.
National policy on Hepatitis B at the Workplace
Tickborne Disease Case Ascertainment Exercise First Quarter DIDE Training Zoonotic Disease Program.
Bioterrorist Agents: Brucellosis. Learning Objectives Become familiar with the following aspects of Brucellosis: Become familiar with the following aspects.
RVF outbreak in SA, Feb - May 2010 JOINT BRIEFING BY: DEPARTMENT OF AGRICULTURE, FORESTRY AND FISHERIES (DAFF) AND DEPARTMENT OF HEALTH.
Q Fever By Karissa montano.
Increase in notified acute respiratory infection clusters in nursing homes: Surveillance 2011 – 2012 in Paca, France Teija Korhonen EPIET fellow, Cire.
 An acute, severe viral infection  First appeared in 1976 in two simultaneous outbreaks  in a village near the Ebola River in the Democratic Republic.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Rash Decisions: The Colorado Experience with “Maybe Measles” Emily Spence Davizon, Colorado Department of Public Health and Environment.
Investigation and Control of Outbreaks of Foodborne Illness Ralph Cordell, PhD.
H1N1 Update October 2009 Patricia Lynn Meyer, BSN, MPH, CIC.
SEVERE ACUTE RESPIRATORY SYNDROME – UPDATE Anne-Claire de Benoist and Delia Boccia, European Programme for Intervention.
Severe Acute Respiratory Syndrome (SARS) Introduction.
Q-fever Coxiella Burnetii Dr. Hani Masaadeh MD PhD.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Environmental Health Role in Investigation & Control of Food Poisoning & Gastrointestinal Infections Hilary Byrne Belfast City Council.
Q Fever Dr Keat Teo (mbbs, Bmedsc, cs) Moora Health Centre
NOROVIRUS OUTBREAK IN A UNIVERSITY TEACHING HOSPITAL O Meara M, O Connor M, Dept of Public Health, Dr. Steevens Hospital Background On March 7th 2006,
Influenza A (H1N1). What is Influenza A (H1N1)? Influenza A(H1N1) is caused by a novel virus that resulted from the reassortment of 4 viruses from pigs,
MERS-CoV (Middle Eastern Respiratory Syndrome) Mike Wade – 16/06/15, updated 23/7/15.
INSERVICE AN INTERACTIVE JOURNEY BY NICK AND JONO.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Mumps Outbreaks Associated with Correctional Facilities Texas
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
Risk factors for human cutaneous anthrax and an enhanced surveillance program of anthrax in livestock, North-West of Bangladesh Regional Training in Animal.
1. Globalization High Mobility of Human Globalization of infectious disease outbreaks Lessons from Pandemic (H1N1) 2009 Concern of next pandemic due to.
Outbreak Investigation
Understanding Epidemiology
Outbreak Investigations
Jill Stauffer Field Epidemiologist – District 8 April 6, 2017
Foot and Mouth Disease Ministry Of Agriculture, Kingdom of Saudi Arabia
Ebola Virus and development
Outbreak Investigations
Utah Zika investigation, July 2016
Outbreak Investigation
Heidi Lord BN MPH South Western Sydney Local Health District
BY DR. MUDAMA PRECIOUS (M.B.B.S., BENIN)
H1N1 Swine Flu Overview by ziffi.com Symptoms, Causes, Prevention, Tests, Test & Vaccination Centers.
Content Public Health Emergencies Ebola Virus Disease: DRC
World Health Organization
EBOLA VIRUS DISEASE Joseph P. Iser, MD, DrPH, MSc Southern Nevada Health District.
Health Surveillance What you need to know
Diagnosed Food Handlers
TYPHOID CASES IN SOUTH AFRICA AND GAUTENG PROVINCE
Introduction to public health surveillance
Dr. Silvia Pessah-Eljay Zoonosis Disease. Epidemiology Division
The Zika Virus & Pregnancy
Epidemiology of hepatitis A in Ireland
Interview Timeframes Conduct a minimum of 2 interviews: 1st interview
Provider comparison reveals no difference between training levels
University of Washington
OIE standards with respect to RVF and trade
Presentation transcript:

A Q fever cluster among workers at an Abattoir in South Western Sydney Heidi Lord1; Stephanie Fletcher – Lartey1; Guy Weerasinghe2; Meena Chandra1;Nilva Egana1; Nicole Schembri2; Stephen Conaty1 1Public Health Unit, South Western Sydney Local Health District, Sydney Australia; 2Greater Sydney Local Land Services, Sydney Australia. Abstract Background: In September 2015, the South Western Sydney Local Health District Public Health Unit (SWSLHD PHU) was notified of two possible Q fever cases. Case investigation identified that both cases were employed at an abattoir with both cases also advising that co-workers had experienced similar symptoms. This prompted an outbreak investigation. Methods: The investigation incorporated active case finding, microbiological analysis, field investigation and risk assessment survey. Included cases were laboratory definitive or suspected cases occurring from October 2014 to October 2015 resident or working in South Western Sydney. A suspected case had clinically compatible illness, high-risk exposure and was epidemiologically linked to another confirmed case. A confirmed case included detection of C. Burnetti by laboratory methods. Results: Eight cases met the case definition, with seven confirmed and one suspected. The eight cases were all males and had been employed at an abattoir in South Western Sydney during their incubation period, with symptom onset dates ranging from November 2014 to September 2015. Field investigation identified multiple potential risk exposures at the abattoir and the majority (75%) of employees were not vaccinated against Q fever despite this high-risk setting. Conclusion: This cluster of Q fever in a single abattoir confirms the significance of this zoonotic disease as an occupational hazard among persons working in this high-risk environment. Implementation of Q fever vaccination programs should eliminate Q fever in high-risk occupational settings. Table 1: Summary of risk assessment findings from the risk assessment questionnaire, South Western Sydney, Australia, 2015 Assessment Criteria Number of cases Current occupation (Abattoir/ slaughter house worker)? 8/8 Experienced Q fever symptoms in past 12 months (combination of the symptoms including fever, severe headaches, muscle aches, extreme fatigue, joint pain, sweating and chills)? Received Q fever vaccine in the past? 2/8 Tested positive for Q fever - blood test only (skin test negative)? Doctor has advised to have ongoing check-ups/ scans or blood tests? 4/8 Worked in a high risk occupation in the month prior to onset of symptoms? (Yes = abattoir) GP or hospital doctor ever requested an echocardiogram or heart scan due to symptoms? 3/8 Still have problems/ symptoms related to Q fever? 5/8 Type of work done in abattoir?   Slaughtering, Boning, Packing, Inspect meat 1/8 Types of animals in contact with as part of abattoir work Cattle Sheep Goats Pigs Contact with fluids from pregnant animals or animals giving birth Animals giving birth Handled carcass / slaughtering of pregnant animal 6/8 Handling of animal foetus or slops bucket Family member living in the same house as case, working in an abattoir? Time lapse before seeing a doctor after first symptoms developed? Immediately to within two weeks Between two weeks and six weeks Methods The two initial Q fever cases notified to PHU were investigated. In addition, enhanced case finding, risk factor survey and field investigation were conducted. Enhanced Case Finding Conducted through a) the abattoir line listing b) routine case notifications c) local faxback system and d) retrospective review of pathology from September to November 2015.The additional cases identified through enhanced case finding were investigated or re-investigated. Risk Factor Survey A modified the risk assessment section of the standard Q fever investigation question package, included additional questions to capture potential risk factors for Q fever, was developed. Cases were asked about symptom profile, occupational risks, vaccination, and exposure to animals outside of their occupational setting. Field investigation An inspection to the implicated abattoir was conducted on 13 October 2015, involving: review of abattoir documentation; gathering information on species slaughtered and wholesalers who provide them to the abattoir; inspection of the kill floor, holding yards and layout and design of the abattoir; review of cleaning practices. Staff knowledge on Q fever was also assessed by asking questions about transmission, vaccination, symptoms and their understanding of abattoir management reporting requirements in relation to Q fever. Results In total, we identified eight cases of Q fever (seven confirmed and one suspected cases) with onset dates ranging from 24 November 2014 to 9 September 2015. All cases were males and had been employed at the implicated abattoir during their incubation period. Most cases had fever (87.5%), followed by headache, chills or rigors, nausea and vomiting (62.5%). Risk assessment surveys were conducted between October 2015 and November 2015, which revealed that only 25% (2/8) of cases had previously received a Q fever vaccination. All eight cases had high-risk exposures during their current employment. None of the cases identified other potential risk exposures outside their occupational setting. Field investigation at the abattoir identified that there were 33 staff currently employed at the abattoir – 23 were employed as “kill staff”, the other 10 staff had roles in management, maintenance and stock handling. Liaison with abattoir management was challenging and low compliance with appropriate work health and safety obligations was evident. The field investigation revealed that management and staff were lacking in knowledge and awareness of Q fever infection. Abattoir management were not compliant in reporting to SafeWork NSW. Possible risk exposures included animals were aborting/giving birth in the holding yards and at the evisceration point. All staff on the kill floor would have potentially been exposed to the aerosolisation of the birthing products. Additionally, staff were observed smoking during their break times indicating a possible hand to mouth exposure. Table 2: Summary of confirmed and suspected cases in the Q fever cluster South Western Sydney, Australia, 2015 Case No. Age, Sex Onset date Lab evidence Investigation classification Symptom Profile 1 17, M 24/11/2014 Definitive seroconversion Confirmed Fever, Headache, Chills and Rigors, Lethargy, Malaise, Vomiting and weight loss 2 28, M 27/11/2014 Definitive - NAT Chills, headache, lethargy and diarrhoea 3 28/11/2014 Abnormal Liver Function Tests, Fever, Lethargy, and Malaise 4 22, M 11/01/2015 Suspected case (no convalescent sample available) Suspected case Fever, Lethargy, Malaise, Sore Throat, Chest pain and Arthralgia 5 27, M 27/07/2015 Abnormal Liver Function Tests, Fever, Chills, Headache, Lethargy and Malaise 6 31/08/2015 Fever, Chills, Vomiting, and Malaise 7 60, M 7/09/2015 (deceased 30/9/2015) Fever, Headache, Lethargy, Malaise, Vomiting, Loss of appetite, and Abnormal Liver Function Tests 8 45, M Abnormal Liver Function Tests, Fever, Chills and Rigors, Headache, Vomiting, Lethargy and Arthralgia Introduction Q fever is a zoonotic disease caused by C. Burnetii in affected humans.1-3 The main reservoirs for transmission of Q fever are cattle, sheep and goats.3-5 Humans are predominately infected through inhalation of airborne dust or droplets containing C. Burnetii bacterium.4-5 The Q fever incubation period is 14 to 21 days, approximately 60% of Q fever infections are asymptomatic4-5 In Australia, human infection with Q fever has been largely attributed to cattle, sheep and goats. A safe and effective Q fever vaccine has been available in Australia since 1989.4 It is recommended in the Australian Immunisation Handbook6 and mandated by SafeWork NSW (a NSW Government Agency for Work Health and Safety Regulation)7 for those employed in high-risk occupations. In NSW, Q fever is a notifiable condition under the Public Health Act 2010. In September 2015, the South Western Sydney Local Health District Public Health Unit (SWSLHD PHU) was notified of two possible Q fever cases. Case investigations revealed that they had been employed at the same abattoir during their incubation period, with no other potential risk exposures identified. These cases also reported that co-workers had also experienced similar symptoms. This prompted further investigation to identify any additional possible or confirmed Q fever cases not notified to the PHU. Discussion This was a large cluster of Q fever in a high risk setting. This current outbreak in South Western Sydney compares with several previous outbreaks in both size and case finding, but particularly the abattoir outbreak in South Australia in 2007 with five confirmed cases and one possible fatal case.8 This investigation has confirmed the significance of this zoonotic disease as an occupational hazard for people working in high risk settings. The application of enhanced surveillance strategies created the opportunity to identify potential cases in the public and within the vicinity of the abattoir – especially given that the field investigation revealed that both school and residential properties were within close proximity to the abattoir. An outbreak in the Netherlands in 2007–2010 was thought to be associated with goat farms that were experiencing a huge number of abortions.9,10 Cases were found to be residing within close proximity to the farms (5 km radius), which were thought to be the primary source of infection precipitated by the dry weather aerosolising the C.burnetti.10 - 13, 14 This demonstrates the necessity for surveillance and active case finding in the area surrounding the abattoir. Interpretation of the NSW Health control guidelines for Q fever case definition requires urgent review for easier interpretation. As PHUs rely on control guidelines to confirm or exclude notifications, unclear guidelines can result in misinterpretation and potentially distort the surveillance data used to inform policy and prevention strategies. Issues in this study arose with the absence of clear guidelines to notify, collaborate or provide recommendations regarding the cluster at the abattoir to SafeWork NSW proved challenging. This investigation also revealed the alarming lack of knowledge amongst abattoir management and staff about the risk of Q fever. Equally disconcerting is the absence of a pre-screening and vaccination program. Poor record keeping at the abattoir made it difficult to identify staff previously employed at the abattoir and what roles they occupied during their period of employment. Although SafeWork NSW issued the abattoir with a warning and compliance order, the sufficiency of this action to mitigate any ongoing risk to employees is questionable. Tighter regulation and increased monitoring by SafeWork NSW may be necessary to ensure pre-screening and vaccination programs and other necessary restrictions and policies are implemented for employees in high-risk occupations. References 1. Healy B, Van Woerden H, Raoult D, Graves S, Pitman J, Lloyd G, Brown N, Llwelyn M. Chronic Q Fever: Different Serological Results in 3 Countries – Results of a Follow-up Study 6 Years After a Point Source Outbreak. Clinical Infectious Diseases. 2011 April15; 52 (8): 1013-1019. 2. Gunaratnam P, Massey P, Eastwood K, Durrheim D, Graves S, Coote D, Fisher L. Diagnosis and management of zoonoses – a tool for general practice. Australian Family Physician. 2014 March; 43 (3): 124 – 128. 3. Hess IM, Massey PD, Durrheim DN, O’Connor S, Graves RG. Preventing Q fever endocarditis: a review of cardiac assessment in hospitalised Q fever patients. Rural and Remote Health. 2011 November 17; 11: 1763 -1771. 4. Massey PD, Irwin M, Durrheim DN. Enhanced Q Fever Risk Exposure Surveillance May Permit Better Informed Vaccination Policy. Commun Dis Intell. 2009; 33 (1): 42-46. 5. Carrieri MP, Tissot-Dupont H, Rey D, Brousse P, Renard H, Obadia Y, Raoult D. Investigation of a Slaughterhouse-Related Outbreak of Q Fever in the French Alps. Eur J Clin Microbiol Infect Dis. 2002; 21: 17-21.. 6. Department of Health [Internet] The Australian Immunisation Handbook [Updated 2016 April 8; cited 2016 May 14] Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook10-home~handbook10part3~handbook10-3-3#3-3-7 7. SafeWork NSW [Internet] Q Fever [Updated 2016 March 31; cited 2016 May 14] Available from: http://www.safework.nsw.gov.au/health-and-safety/safety-topics-a-z/diseases/q-fever 8. ProMed mail. Q fever- Australia (SA) (02): abattoir. 2007. [cited 2016 May 14] Available from: http://promedmail.org/post/20070713.2244 9. Bults M, Beaujean D, Wijkmans C, Richardus JH, Voeten H. Q fever in the Netherlands: public perceptions and behavioural responses in three different epidemiological regions: a follow-up study. BMC Public Health. 2014; 14: 263 – 277. 10. Delsing CE, Kullberg BJ. Q fever in the Netherlands: a concise overview and implications of the largest ongoing outbreak. The Netherlands Journal of Medicine. 2008; 66 (9): 365 – 367. 11. Roest HIJ, Tilburg JJHC, Van Der Hoek W, Vellema P, Van Zijderveld FG, Klaassen CHW, Raoult D. The Q fever epidemic in The Netherlands: history, onset, response and reflection. Epidemiol. Infect. 2011; 139: 1-12. 12. Schimmer B, Ter Schegget R, Wegdam M, Züchner L, de Bruin A, Schneeberger PM, Veenstra T, Vellema P, Van Der Hoek W. The use of a geographic information system to identify a dairy goat farm as the most likely source of an urban Q-fever outbreak. BMC Infect Dis. 2010; 10: 69 – 76. 13. Georgiev M, Afonso A, Neubauer H, Needham H, Thiéry R, Rodolakis A, Roest HJ, Stärk KD, Stegeman JA, Vellema P, van der Hoek W, More SJ. Q fever in humans and farm animals in four European countries, 1982 to 2010. Euro Surveill. 2013;18(8): 1-13. 14. Gilroy N, Formica N, Beers M, Egan A, Conaty S, Marmion B. Abattoir-associated Q fever: a Q fever outbreak during a Q fever vaccination program. Australian and New Zealand Journal of Public Health. 2001; 25 (4): 362 – 367.